Importance of Radioactive Labelling to Elucidate Inositol Polyphosphate Signalling
- 792 Downloads
Inositol polyphosphates, in their water-soluble or lipid-bound forms, represent a large and multifaceted family of signalling molecules. Some inositol polyphosphates are well recognised as defining important signal transduction pathways, as in the case of the calcium release factor Ins(1,4,5)P3, generated by receptor activation-induced hydrolysis of the lipid PtdIns(4,5)P2 by phospholipase C. The birth of inositol polyphosphate research would not have occurred without the use of radioactive phosphate tracers that enabled the discovery of the “PI response”. Radioactive labels, mainly of phosphorus but also carbon and hydrogen (tritium), have been instrumental in the development of this research field and the establishment of the inositol polyphosphates as one of the most important networks of regulatory molecules present in eukaryotic cells. Advancements in microscopy and mass spectrometry and the development of colorimetric assays have facilitated inositol polyphosphate research, but have not eliminated the need for radioactive experimental approaches. In fact, such experiments have become easier with the cloning of the inositol polyphosphate kinases, enabling the systematic labelling of specific positions of the inositol ring with radioactive phosphate. This approach has been valuable for elucidating their metabolic pathways and identifying specific and novel functions for inositol polyphosphates. For example, the synthesis of radiolabelled inositol pyrophosphates has allowed the discovery of a new protein post-translational modification. Therefore, radioactive tracers have played and will continue to play an important role in dissecting the many complex aspects of inositol polyphosphate physiology. In this review we aim to highlight the historical importance of radioactivity in inositol polyphosphate research, as well as its modern usage.
KeywordsRadioactivity Inositol Pyrophosphates Metabolism Phosphate
This PLC activity was indirectly assayed during the first discovery of receptor-stimulated inositol polyphosphate metabolism. In the early 1950s, the Hokin husband and wife team were studying RNA metabolism using radioactive orthophosphate [32P] metabolic labelling, when they discovered an increase in cellular incorporation of radioactivity when pancreatic slices were stimulated with acetylcholine. Surprisingly, however, the large majority of radioactivity was not incorporated into nucleic acids but into the inositol-containing lipids called phosphoinositides (PI or PtdInsP, phosphatidylinositols); this acetylcholine-stimulated [32P] incorporation was therefore termed the “PI response” [8, 9]. It was not until three decades later that the PI response was determined to be part of PLC activation [6, 10] (Fig. 1). The [32P] taken up is initially incorporated into ATP and other nucleotides. Radioactive phosphorylation of DAG to phosphatidic acid (PA) allows its reattachment to inositol, creating PtdIns that is further phosphorylated, generating the radioactive PtdInsP/“PI” that the Hokins observed, and completing what is now known as the inositol cycle (Fig. 1).
This short historical background highlights the fundamental importance of radioactive phosphate labelling in the birth of the phosphoinositide and inositol polyphosphate signalling research fields. Equally, everyone is aware of the historical—and indeed, current—importance of radioactive labelling in nucleic acid research . Without radioactivity-based methods, molecular biology would not have emerged and we would not be in the post-genomic era of biomedical research. It is not an overstatement to say that without radioactivity, the advances in biomedical science and consequent improvements in human health of the past century would not have been achieved. The ongoing importance of radioactive labelling to inositol polyphosphate research should also not be underestimated.
The general perception of “radioactivity” is one of fear, and understandably so, considering famous disasters such as those at Chernobyl or Fukushima . However, using very low trace levels of radioactivity in a highly controlled research environment is safe: many protection and monitoring measures are available [13, 14]. Young researchers should therefore embrace radioactivity-based techniques, as they offer unique research opportunities, even in this twenty-first century, and especially in the inositol polyphosphate research field. Inositol polyphosphates, being unable to absorb UV/visible wavelength light, cannot be detected by absorbance or fluorescence methods. Thus the study of their metabolism and physiological functions has only been possible through radioactivity experiments. The current essay will focus primarily on the importance of radioactive phosphate labelling ([32P] and [33P]) in inositol polyphosphate biology. We will discuss the use of radioactive orthophosphate tracers to study the cellular metabolism of inositol polyphosphates, as well as the biochemical synthesis and purification of inositol polyphosphates radiolabelled at specific positions on the inositol ring. To provide a complete view of relevant radioactive methods, we will also concisely describe the use of radioactive hydrogen (tritium [3H]) and carbon (carbon-14 or [14C]) labelling techniques.
2 Phosphoinositides and Inositol Phosphates
Together, Ins(1,3,4,5,6)P5 and InsP6 are the major forms of inositol polyphosphates present in mammalian cells. Despite their association with numerous cellular functions, and unlike Ins(1,4,5)P3, no dramatic or rapid changes in the cellular amount of either molecule are seen on receptor activation, although their relative level is modulated by neurotrophin signals . However, they are not metabolically inert: Ins(1,3,4,5,6)P5 and InsP6 are substrates for the synthesis of a subfamily of inositol polyphosphates called inositol pyrophosphates [37, 38, 39]. These contain one or more high-energy phosphoanhydride (pyro) bonds as well as the phosphoesters. Two classes of enzyme synthesise inositol pyrophosphates in mammalian cells. The IP6Ks (InsP6 kinase) are able to pyrophosphorylate position 5 of the inositol ring, generating 5PP-InsP5 (diphosphoinositol pentakisphosphate, InsP7) from InsP6 or 5PP-InsP4 from Ins(1,3,4,5,6)P5 [25, 38, 39, 40, 41, 42, 43]. Alternatively, PPIP5K (VIP1 in yeast) enzymes can pyrophosphorylate position 1, generating the 1PP-InsP5 isomer of InsP7 from InsP6 in vitro [44, 45, 46, 47], and InsP8 ([PP]2-InsP4; bis-diphosphoinositol-tetrakisphosphate) from 5PP-InsP5 in vivo [48, 49].
Inositol phosphate kinases identified in the human and yeast (S. cerevisiae) genomes
Inositol polyphosphate kinase
Main enzymatic activities
Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Inositol polyphosphate multikinase
Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Ins(1,3,4,5)P4 => Ins(1,3,4,5,6)P5
PtdIns(4,5)P2 => PtdIns(3,4,5)P2
Ins(1,3,4)P3 => Ins(1,3,4,5)P4
Ins(1,3,4,5)P4 => Ins(1,3,4,5,6)P5
Ins(3,4,5,6)P4 => Ins(1,3,4,5,6)P5
Inositol pentakisphosphate 2-kinase
Ins(1,3,4,5,6)P5 => InsP6
Inositol hexakisphosphate kinase
InsP6 => 5PP-InsP5
1PP-InsP5 => (1,5)PP2-InsP4
Ins(1,3,4,5,6)P5 => PP-InsP3
Diphosphoinositol pentakisphosphate kinase
InsP6 => 1PP-InsP5
5PP-InsP5 => (1,5)PP2-InsP4
3 Radioactive Labels for Inositol
Isotopic labels available to generate inositol polyphosphate radioactive tracers
Range in air
Tritium contains two neutrons as well as the usual hydrogen proton. It is a weak β-emitter with a half-life of over 12 years. The emitted electron has very low energy, and can therefore travel only a few millimetres in air, and cannot penetrate the skin. This makes it particularly easy to work with, as special protective equipment is not required: gloves, goggles and lab coat are sufficient. On the minus side, the emitted radiation is too low to be detected by Geiger counter. Testing for tritium contamination before and after an experiment must instead be performed by swipe testing and liquid scintillation counting. Carbon-14 has a very long half-life, enabling its use in carbon dating in archaeology. The emitted electrons are still reasonably low-energy, although they can be detected using a Geiger counter, and can travel less than 0.3 mm into the skin. Therefore, shielding is also not necessary when working with [14C].
Phosphorus-32 is the most energetic radioisotope commonly used in biochemical laboratories. The electrons released are very high-energy and can travel over 6 m through air and 0.76 cm into human tissues. Consequently, extra precautions are required when working with [32P]: a 1 cm Plexiglas shield is required for the working area, and dosimeter monitoring for the experimenter. Contamination is easily detected with a Geiger counter. Experiments requiring [32P] can also be performed using the superior phosphorus-33 isotope. The emitted radiation from [33P] is of lower energy and is therefore less dangerous, although the same safety measures are required. The half-life of [33P] is also longer than that of [32P]: 25.4 days compared to 14.3 days. This can be extremely beneficial in maximising the value of any radiolabelled compounds synthesised. Only very rare experimental circumstances require the high energy of [32P] radiation, but this isotope is still widely used, since there is a huge price difference between the two radioactive isotopes. Phosphorus-33 is much more expensive.
4 Inositol Polyphosphate in Vivo Studies Using Radioactive Metabolic Labelling
As mentioned above, the main problem for inositol polyphosphate research is that there is no easy way to detect the inositol ring using spectrophotometry. A technique was developed in the 1980s that combined chromatography, post-column derivatisation and spectrophotometry to visualise the phosphate groups, and thus indirectly the inositol polyphosphate, to try to solve this problem . This method is not sensitive enough to be routinely used with mammalian cells, although there are a few reports of its use ; it may be more appropriate for organisms with high levels of inositol polyphosphates such as the amoeba Dictyostelium discoideum [3, 51]. In general, for effective, sensitive and reliable methods for detecting and studying the metabolism and many functions of inositol polyphosphates, we must turn to radioactivity.
The standard procedures for investigating inositol polyphosphate metabolism in vivo require the use of radiolabelled inositol tracers [52, 53]. These are usually based on tritium labels, with carbon-14 rarely used, as it is more expensive (Fig. 2b, c). These [3H]inositol or [14C]inositol tracers (Fig. 2b, c) are added to the extracellular growth medium, where they are taken up by cells and enter the inositol cycle (Figs. 1, 3). Different inositol polyphosphates and phosphoinositides then begin to be radiolabelled. The labelling must be given sufficient time to reach isotopic equilibrium, where all the inositol polyphosphates species are in equilibrium with [3H]inositol or [14C]inositol. Given the presence of more than 30 inositol polyphosphate species in eukaryote cells [15, 17], and that, for example, seven sequential enzymatic reactions are required to generate InsP7, it is clear that allowing time to reach isotopic equilibrium is fundamental to generating reliable experimental data. For yeast, it is normally sufficient to label the cells overnight, which corresponds to 7–8 cell divisions. Unsurprisingly, mammalian cells must be labelled for much longer to reach equilibrium: 4 or 5 days may be enough, depending on cell type. Before starting labelling experiments in a new cell type, a pilot study must be performed to determine the time needed to reach metabolic equilibrium . This is calculated by dividing the radioactivity accumulated in InsP6 by the radioactivity of the lipid phosphoinositide pool. This InsP6/phosphoinositide ratio increases over time; when it remains constant, the labelling has reached equilibrium. In the modern literature, too often the isotopic equilibrium is not properly calculated or even considered, casting doubt on the reliability of the data generated.
Once metabolic equilibrium has been reached, radiolabelled inositol polyphosphates can be acid-extracted and resolved by strong anion exchange high-performance liquid chromatography (saxHPLC). Two options exist for analysing the samples. Firstly, an in-line radioactivity detector can be used, greatly speeding up analysis and reducing handling at the cost of sensitivity. The alternative is to collect fractions for manual counting with a scintillation β-counter; while more labour-intensive, this method significantly increases the sensitivity. The inositol pyrophosphate species InsP7 and InsP8 can be easily detected in labelled yeast extracts using manual counting [52, 54], while only the more abundant precursor InsP6 has been identified using in-line detectors .
It should also be mentioned that dual isotopic labelling is possible. The difference in the energy of electrons emitted by [3H]inositol and [14C]inositol enables scintillation counters to distinguish these two inositol species. By labelling cells to isotopic equilibrium using [14C]inositol, and then briefly with [3H]inositol, it is possible to study the possible heterogeneity within pools of phosphoinositides or inositol polyphosphates . This approach was employed successfully in the study of inositol polyphosphates generated after vasopressin or prostaglandin stimulation of vascular tissue. Their source was found to be rapidly labelled phosphoinositides, while the bulk of the highly phosphorylated inositol polyphosphates InsP5 and InsP6 were not created from the rapid phosphoinositide turnover, and were therefore deemed metabolically inert . Dual labels can also have more technical uses. Chiefly, a second isotopic label is widely used to determine chromatographic saxHPLC peak identity: spiking a [3H]inositol labelled extract with a [14C]inositol polyphosphate standard enables conclusive identification of the nature of the eluted peaks .
The use of commercially available radiolabelled standards would of course be ideal. Unfortunately, many inositol polyphosphates, including InsP7, are not available commercially in their radiolabelled form or often even in unlabelled format. The next best option for peak identification is to use the well-characterised yeast inositol kinase mutant strains. Separation of radiolabelled wild-type yeast extracts by saxHPLC reveals a simple elution profile with one major peak of InsP6 and two smaller, more polar and therefore later-eluting peaks of InsP7 and InsP8. These two peaks are absent in extracts from kcs1Δ (IP6K mutant) yeast. The vip1Δ mutant instead accumulates InsP7 [48, 49]. Other mutants show increased peaks for inositol polyphosphates: Ins(1,4,5)P3 accumulates in arg82Δ multikinase mutants , while Ins(1,3,4,5,6)P5 accumulates and is converted by Kcs1 into PP-IP4 in an ipk1Δ mutant. The ipk1Δkcs1Δ double mutant has only the increased InsP5 peak . Radiolabelled inositol polyphosphate standards can also be generated in vitro enzymatically, whether using radioactive inositol polyphosphate precursors or cold inositol polyphosphates with [32P]γATP (as described below). Laboratories with a serious interest in inositol polyphosphate analysis would do well to create standards with a long half-life: extracting and purifying specific inositol polyphosphates from [3H]inositol- or [14C]inositol-labelled cells gives defined standards that can be used over several years [24, 57].
While radioactive orthophosphate labelling has been instrumental in the early development [58, 59, 60] of the inositol phosphate research field, it must be admitted that [32P] or [33P] orthophosphate labelling currently has limited use for in vivo analysis of inositol polyphosphate metabolism. Many phosphorylated molecules in eukaryotic cells, primarily the abundant nucleotides, are co-purified during the acidic extraction normally employed to purify inositol polyphosphates. Therefore, any chromatogram is essentially undecipherable until the nucleotides have eluted off. The interfering nucleotides can be removed first by charcoal treatment, but this complicates the extraction procedure . For this reason, only a handful of papers published after the 1990s have reported the use of phosphate labelling to study inositol polyphosphate metabolism in vivo. One such use was the original identification of inositol pyrophosphates in D. discoideum extracts : the saxHPLC elution region for these high-polarity molecules in this organism is conveniently free from interference from contaminating phosphorylated molecules. This is not the case for extracts from cell types rich in the linear polymer of phosphates [62, 63] inorganic polyphosphate (polyP), such as yeast or trypanosomes, where polyP is particularly abundant [64, 65, 66]. In these organisms, orthophosphate labelling experiments will reveal the continuous presence throughout the chromatogram of radiolabelled polyP peaks that cover the InsP6, InsP7 and InsP8 signals (A. Saiardi, unpublished observation).
Orthophosphate labelling using [32P] or [33P] is more useful in studies of PtdIns lipids. While several types of potentially contaminating phospholipids exist, their number is not as great as the water-soluble (i.e., acid-extracted) phosphorylated molecules present in eukaryotic cytosol. Furthermore, nucleotides are eliminated by the organic solvent extraction procedure required to purify phosphoinositides. Thus it is possible to identify and study radiolabelled phosphoinositides directly, using thin-layer chromatography (TLC) or by resolution by saxHPLC after deacylation . The highly energetic phosphate isotopes also allow the use of in-line radioactive detection methods to measure the saxHPLC-eluted deacylated lipids. It is important to note that orthophosphate [32P] or [33P] labelling is usually performed over a short period of time, from a few minutes to a few hours only. The phosphorus isotopes are toxic to the cell, and incubation over a few days induces cell stress or even death. Furthermore, orthophosphate labelling does not require reaching any isotopic equilibrium. Tritium or [14C] labels are components of the inositol ring itself (Fig. 1b, c), while phosphate labels are not: they are added and removed by the dynamic action of specific phosphatases and kinases, and thus isotopic equilibrium labelling is not necessary.
5 Biochemical Synthesis of 32/33Phosphate Radiolabelled Inositol Polyphosphates
Even before the cloning of inositol polyphosphate kinases, allowing the synthesis and purification of recombinant enzymes from bacteria, partially purified enzymatic activities or simple cell extracts were used to synthesise radiolabelled inositol polyphosphates [68, 69]. The synthesis of these molecules, labelled with radioactive phosphate at specific positions of the ring, has had numerous applications, including as standards, for monitoring enzymatic activity, or even the discovery of the new post-translational modification protein pyrophosphorylation. Most of the metabolic pathways and functions of lower phosphorylated inositol polyphosphates were elucidated before the cloning of the kinases responsible for their synthesis, often using elegant [32P] radiolabelled biochemical assays [70, 71, 72, 73]. Studies of the functions of the higher phosphorylated inositol polyphosphates, such as InsP5, InsP6, and their inositol pyrophosphate derivatives have benefitted from this previous knowledge and by the cloning of their kinases. Using one of the six now known inositol polyphosphate kinases (Table 1) and [32/33P]γATP, it is possible to label almost any position of the inositol ring with radioactive phosphate. We will start by discussing the use of recombinant ITPKA, an IP3-3 kinase, to generate InsP4 labelled at position 3.
6 Synthesis of [32P]i Radiolabelled InsP4 and Its Use
The biosynthesis of [32P]InsP4 can be achieved by incubating ITPKA with Ins(1,4,5)P3 and [32P]γATP. This enzyme specifically phosphorylates position 3 of the ring, and thus generates 3[32P]Ins(1,3,4,5)P4 . Several studies have used this method to investigate the metabolism of this isomer. Notably, its degradation by inositol polyphosphate 5-phosphatases (namely SHIP1/2) can be studied by following the formation of the radiolabelled and thus easily traceable 3[32P]Ins(1,3,4)P5 . The anabolism of 3[32P]Ins(1,3,4,5)P4 and conversion to [32P]InsP6 has also been studied after incubation with nuclear extracts from D. discoideum .
SHIP2 is more famous for its ability to convert PtdIns(3,4,5)P3 to PtdIns(3,4)P2, thus regulating the signal from these two important lipids . To study SHIP activity against lipids, radiolabelled [32P]PtdInsP3 substrate may be required. Previously, PI3Ks were employed to create this, but these are large proteins for which recombinant expression from bacteria is difficult. A current alternative is to use IPMK, which can act on not only the soluble InsP(1,4,5)P3 but also the lipid PtdIns(4,5)P2 , allowing straightforward synthesis of 3[32P]PtdIns(3,4,5)P3, specifically labelled in position 3 . Human IPMK is easily produced from Escherichia coli [26, 78].
7 Preparing [32P]i Radiolabelled InsP5 and Its Use
A different [32P]Ins(1,3,4,5,6)P5 radiolabelled isomer was initially purified from metabolically labelled cells [72, 87]. It can now be made using IPMK with Ins(1,4,5)P3 and [32P]γATP, generating 3,6[32P]Ins(1,3,4,5,6)P5 (Fig. 4). Similarly, [3H]Ins(1,3,4,5,6)P3 is generated by incubating recombinant IPMK with the commercially available [3H]Ins(1,3,4,5)P4 and ATP. Both radiolabelled reagents 3,6[32P]Ins(1,3,4,5,6)P5 and [3H]Ins(1,3,4,5,6)P5 have been employed to great effect in studying the metabolic stability of InsP5 and its anti-tumour capability .
8 Preparing [32P]i Radiolabelled InsP6 and Its Use
The commercial availability of [3H]InsP6 has been intermittent over the years. This is unfortunate, as it was indispensable, for example, in the cloning of the IP6K enzymes from rat brain homogenate: the conversion of [3H]IP6 to [3H]InsP7 was followed using polyethylenimine cellulose thin-layer chromatography (PEI-TLC) [25, 68]. The custom synthesis of [32P]InsP6 was similarly essential to the identification of the other class of enzymes, PPIP5Ks, able to synthesise inositol pyrophosphates. High specific activity [32P]InsP6 can be generated enzymatically by incubating Ins(1,3,4,5,6)P5 and [32P]γATP with recombinant Arabidopsis thaliana IPK1 enzyme . After HPLC purification, this enzymatic reaction generates [32P]IP6 specifically labelled in position 2, i.e., 2[32P]Ins(1,2,3,4,5,6)P6. The use of this compound spurred the identification, cloning and characterisation of the yeast PPIP5K (Vip1), since its conversion to [32P]InsP7 by kcs1Δ (IP6K deletion) yeast extracts revealed the presence of another inositol pyrophosphate synthase activity . Radiolabelled [32P]InsP6 has also been used to follow IP6K activity during the yeast cell cycle  by simply resolving radioactive [32P]IP6 and [32P]IP7 by PEI-TLC. In addition to eliminating the need for a sophisticated HPLC apparatus, this experimental approach is quantitative, since the radioactivity present in the [32P]InsP6 and [32P]InsP7 TLC spots can be measured by scraping and counting them in a scintillation counter.
9 Preparing [32P]i Radiolabelled InsP7 and Its Use in Protein Pyrophosphorylation Reactions
Performing the in vitro pyrophosphorylation/transphosphorylation experiment, once 5[32P]βInsP7 is synthesised, is a straightforward process. However, it is important to remember the requirement for a pre-phosphorylated serine residue as substrate. Thus proteins of bacterial origin, such as recombinant mammalian proteins expressed in E. coli, require a priming event by a classical ATP kinase, usually casein kinase 2 (CK2) [93, 94]. The 5[32P]βInsP7 pyrophosphorylation is a non-enzymatic, temperature-dependent event that, while it does occur at physiological temperatures, is enhanced by incubating the sample at higher temperatures . Once pyrophosphorylated, proteins can be resolved by polyacrylamide gel electrophoresis (PAGE), and their radioactivity incorporation can be easily identified by autoradiography. Several substrates of InsP7-mediated pyrophosphorylation have been identified so far. A common feature to all is stretches of serines embedded in regions rich in acidic residues; as magnesium is required for pyrophosphorylation, it is possible that the acidic residues are required to coordinate these ions. Pyrophosphorylated proteins are more acid-labile but also more resistant to phosphatases than proteins phosphorylated by ATP alone . If this is true in vivo, it could have huge implications for cellular signalling: InsP7-mediated protein pyrophosphorylation could act in a dominant manner to allow continued signalling even during phosphatase activation.
It is important to note that inositol pyrophosphates appear to be interchangeable in their ability to pyrophosphorylate proteins. For example, 1[32P]βInsP7 synthesised using the Vip1 (PPIP5K) kinase domain and [32P]γATP (Fig. 5) is able to pyrophosphorylate proteins, as is 1,5[32P]InsP8 synthesised by the double action of IP6K1 and Vip1. In fact, the incubation of S. cerevisiae extracts with 5[32P]βInsP7, 1[32P]βInsP7 or 1,5[32P]βInsP8 revealed an identical pattern of pyrophosphorylated proteins . This indicates that if pyrophosphorylation is the mechanism of action for inositol pyrophosphates, they can substitute for each other in performing their biological role. However, allosteric regulation of proteins has also been proposed as a mechanism [98, 99], and in this circumstance, different isomeric species of inositol pyrophosphates could be recognised by specific effector proteins.
The synthesis described here for 5[32P]βInsP7 is a straightforward procedure, as is using it to identify pyrophosphorylated proteins. However, processing millicurie amounts of radioactivity to generate a reagent with a two week half-life requires a degree of dedication. Therefore, protein pyrophosphorylation, while considered an exciting post-translational modification, has received little attention, as only a handful of laboratories have invested in the synthesis of 5[32P]βInsP7. The recent development of organic synthesised experimental tools to study protein pyrophosphorylation [100, 101] will likely lead to the further and very welcome development of non-radioactive detection methods, and to the demonstration of the existence of this modification in vivo. These developments will certainly increase interest in protein pyrophosphorylation, but it must be remembered that it was the innovative use of radioactive labelling methods that permitted the discovery of this modification in the first place. This is an excellent demonstration that original radioactive assays should not be avoided.
In today’s “omics” era, radioactive labelling appears anachronistic. Current proteomic, metabolomic or genomic studies give us plentiful information in an ever-growing number of databases. Ultimately, however, these huge amounts of data must not be just statistically annotated, but must drive biochemistry experiments, which as noted before, provide the only experimental basis for the understanding of biological mechanisms [102, 103]. In this context, radioactive molecular tracers have played and will continue to play a contributory role in our quest to understand the molecular mechanisms of life.
This review has highlighted the fundamental importance of radioactive labelling in the birth and the development of inositol polyphosphate research. Although recent technological development efforts such as PAGE analysis  and TiO2 extraction of inositol polyphosphates  are facilitating the study of the metabolism and functions of these molecules without the need for radioactive precursors or metabolic labelling, we definitely foresee further need for phosphate-32/33-, carbon-14- or tritium-based experiments to fully appreciate the importance of these molecules in cell biology.
We wish to thank the members of the Saiardi laboratory for reading of the manuscript. We have tried to review all the relevant literature, but we may have missed some specific work; therefore, we would like to apologise to colleagues whose research was not properly recognised. This work is supported by the Medical Research Council (MRC) core support to the MRC/UCL Laboratory for Molecular Cell Biology University Unit (MC_U122680443).
- 2.Menniti FS et al (1993) Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells. J Biol Chem 268(6):3850–3856Google Scholar
- 3.Stephens L et al (1993) The detection, purification, structural characterization, and metabolism of diphosphoinositol pentakisphosphate(s) and bisdiphosphoinositol tetrakisphosphate(s). J Biol Chem 268(6):4009–4015Google Scholar
- 9.Hokin MR, Hokin LE (1953) Enzyme secretion and the incorporation of P32 into phospholipides of pancreas slices. J Biol Chem 203(2):967–977Google Scholar
- 14.Meisenhelder J, Semba K (2001) Safe use of radioisotopes. Curr Protoc Cell Biol Appendix 1: p. Appendix 1DGoogle Scholar
- 16.Resnick AC, Saiardi A (2008) Inositol Polyphosphates. In: Begley TP (ed) Wiley Encyclopedia of Chemical Biology. Wiley, HobokenGoogle Scholar
- 57.Hughes PJ et al (1989) The regulation of the phosphorylation of inositol 1,3,4-trisphosphate in cell-free preparations and its relevance to the formation of inositol 1,3,4,6-tetrakisphosphate in agonist-stimulated rat parotid acinar cells. J Biol Chem 264(33):19871–19878Google Scholar
- 72.Stephens LR, Downes CP (1990) Product-precursor relationships amongst inositol polyphosphates. Incorporation of [32P]Pi into myo-inositol 1,3,4,6-tetrakisphosphate, myo-inositol 1,3,4,5-tetrakisphosphate, myo-inositol 3,4,5,6-tetrakisphosphate and myo-inositol 1,3,4,5,6-pentakisphosphate in intact avian erythrocytes. Biochem J 265(2):435–452CrossRefGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.